T7707430
Salmeterol Xinafoate , >98.0%(T)(HPLC) , 94749-08-3
Synonym(s):
(±) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate;GR 33343X xinafoate;Salmeterol xinafoate
| Pack Size | Price | Stock | Quantity |
| 250mg | RMB1592.00 | In Stock |
|
| 1g | RMB3992.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 137-138°C |
| storage temp. | 2-8°C |
| solubility | H2O: slightly soluble |
| form | solid |
| color | white |
| Merck | 14,8337 |
| InChIKey | XTZNCVSCVHTPAI-UHFFFAOYSA-N |
Description and Uses
Salmeterol hydroxynaphthoate is a new long-acting β2-selective adrenoceptor agonist introduced as a bronchodilator for the treatment of reversible airway obstruction in asthma and chronic bronchitis. It has bronchodilatory activity as intense and four times longerlasting than equivalent doses of salbutamol. Salmeterol hydroxynaphthoate is reported to be the first bronchodilator with significant anti-inflammatory activity and hence could complement prophylactic corticosteroid therapy.
Bronchodilator; Beta2-adrenoceptor agonist
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P280-P271 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 22-24/25-36-26 |
| WGK Germany | 3 |
| RTECS | QJ1970500 |
| HS Code | 2922504500 |
